How Regulators Are Setting Standards For Digital Health Technologies: ADDS Atlanta 2026

Digital health technologies (DHTs) are reshaping clinical research, but regulatory expectations are evolving just as quickly. These on-demand sessions from the ADDS 2026 conference bring together regulatory authorities from the FDA and industry leaders to share practical, data-backed insights on building DHT strategies that hold up to regulatory scrutiny. Through four featured presentations, viewers gain a clearer picture of how official guidance is being applied in practice and how pre-competitive collaboration is accelerating the development of rigorous, real-world evidence.